TY - JOUR AU - Lee, J. A. AU - Grumbach, M. M. AU - Clark, O. H. PY - 2007 DA - 2007// TI - The optimal treatment for pediatric Graves’ disease is surgery JO - J Clin Endocrinol Metab VL - 92 UR - https://doi.org/10.1210/jc.2006-1238 DO - 10.1210/jc.2006-1238 ID - Lee2007 ER - TY - JOUR AU - Cooper, D. S. PY - 2005 DA - 2005// TI - Antithyroid drugs JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMra042972 DO - 10.1056/NEJMra042972 ID - Cooper2005 ER - TY - JOUR AU - Smith, J. AU - Brown, R. S. PY - 2007 DA - 2007// TI - Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves’ disease treated using antithyroid medication JO - Thyroid VL - 17 UR - https://doi.org/10.1089/thy.2007.0072 DO - 10.1089/thy.2007.0072 ID - Smith2007 ER - TY - STD TI - Rivkees SA, Stephenson K, Dinauer C. Adverse events associated with methimazole therapy of Graves’ disease in children. Int J Pediatr Endocrinol. 2010; Epub. ID - ref4 ER - TY - STD TI - Rivkees SA. 63 years and 715 days to the “boxed warning”: unmasking of the propylthiouracil problem. Int J Pediatr Endocrinol. 2010; Epub. ID - ref5 ER - TY - JOUR AU - Rivkees, S. A. AU - Mattison, D. R. PY - 2009 DA - 2009// TI - Ending propylthiouracil-induced liver failure in children JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMc0809750 DO - 10.1056/NEJMc0809750 ID - Rivkees2009 ER - TY - STD TI - Rivkees SA, Mattison DR. Propylthiouracil (PTU) hepatotoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol. 2009; Epub. ID - ref7 ER - TY - JOUR AU - Russo, M. W. AU - Galanko, J. A. AU - Shrestha, R. AU - Fried, M. W. AU - Watkins, P. PY - 2004 DA - 2004// TI - Liver transplantation for acute liver failure from drug induced liver injury in the United States JO - Liver Transpl VL - 10 UR - https://doi.org/10.1002/lt.20204 DO - 10.1002/lt.20204 ID - Russo2004 ER - TY - JOUR AU - Minamitani, K. AU - Oikawa, J. AU - Wataki, K. AU - Kashima, K. AU - Hoshi, M. PY - 2011 DA - 2011// TI - A report of three girls with antithyroid drug-induced agranulocytosis; retrospective analysis of 18 cases aged 15 years or younger reported between 1995 and 2009 JO - Clin Pediatr Endocrinol VL - 20 UR - https://doi.org/10.1297/cpe.20.39 DO - 10.1297/cpe.20.39 ID - Minamitani2011 ER - TY - JOUR AU - Salama, A. AU - Schutz, B. AU - Kiefel, V. AU - Breithaupt, H. AU - Mueller-Eckhardt, C. M. PY - 1989 DA - 1989// TI - Immune-mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies JO - Br J Haematol VL - 72 UR - https://doi.org/10.1111/j.1365-2141.1989.tb07672.x DO - 10.1111/j.1365-2141.1989.tb07672.x ID - Salama1989 ER - TY - JOUR AU - Yang, J. AU - Xiao, X. H. AU - Zhou, L. Z. AU - Chen, Y. J. AU - Liu, J. H. AU - Cao, R. X. AU - Wen, G. B. PY - 2013 DA - 2013// TI - The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis JO - Endocr J VL - 60 UR - https://doi.org/10.1507/endocrj.EJ12-0332 DO - 10.1507/endocrj.EJ12-0332 ID - Yang2013 ER - TY - STD TI - Rivkees SA. Pediatric Graves’ disease: management in the post-propylthiouracil Era. Int J Pediatr Endocrinol. 2014; Epub. ID - ref12 ER - TY - JOUR AU - Takata, K. AU - Kubota, S. AU - Fukata, S. AU - Kudo, T. AU - Nishihara, E. PY - 2009 DA - 2009// TI - Methimazole-induced agranulocytosis in patients with Graves’ disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily JO - Thyroid VL - 19 UR - https://doi.org/10.1089/thy.2008.0364 DO - 10.1089/thy.2008.0364 ID - Takata2009 ER - TY - JOUR AU - Sheng, W. H. AU - Hung, C. C. AU - Chen, Y. C. AU - Fang, C. T. AU - Hsieh, S. M. PY - 1999 DA - 1999// TI - Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections JO - Q J Med VL - 92 UR - https://doi.org/10.1093/qjmed/92.8.455 DO - 10.1093/qjmed/92.8.455 ID - Sheng1999 ER - TY - JOUR AU - Tamai, H. AU - Mukuta, T. AU - Matsubayashi, S. AU - Fukata, S. AU - Komaki, G. PY - 1993 DA - 1993// TI - Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF) JO - J Clin Endocrinol Metab VL - 77 ID - Tamai1993 ER - TY - JOUR AU - Fukata, S. AU - Kanji, K. AU - Sugawara, M. PY - 1999 DA - 1999// TI - Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study JO - Thyroid VL - 9 UR - https://doi.org/10.1089/thy.1999.9.29 DO - 10.1089/thy.1999.9.29 ID - Fukata1999 ER - TY - JOUR AU - Rivkees, S. A. AU - Sklar, C. AU - Freemark, M. PY - 1998 DA - 1998// TI - Clinical review 99: The management of Graves’ disease in children, with special emphasis on radioiodine treatment JO - J Clin Endocrinol Metab VL - 83 ID - Rivkees1998 ER - TY - JOUR AU - Read, C. H. AU - Tansey, M. J. AU - Menda, Y. PY - 2004 DA - 2004// TI - A thirty-six year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves’ patients JO - J Clin Endocrinol Metab VL - 89 UR - https://doi.org/10.1210/jc.2003-031223 DO - 10.1210/jc.2003-031223 ID - Read2004 ER - TY - JOUR AU - Rivkees, S. A. AU - Dinauer, C. PY - 2007 DA - 2007// TI - An optimal treatment for pediatric Graves’ disease is radioiodine JO - J Clin Endocrinol Metab VL - 92 UR - https://doi.org/10.1210/jc.2006-1239 DO - 10.1210/jc.2006-1239 ID - Rivkees2007 ER -